Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Thompson, MC; Harrup, RA; Coombs, CC; Roeker, LE; Pu, JJ; Choi, MY; Barr, PM; Allan, JN; Simkovic, M; Leslie, L; Rhodes, J; Chong, EA; Kamdar, M; Skarbnik, A; Lansigan, F; McCall, B; Saja, K; Dyer, MJS; Walter, HS; Lefebure, M; Thadani-Mulero, M; Boyer, M; Biondo, J; Sail, K; Manzoor, BS; Furman, R; Bantilan, KS; Goy, A; Feldman, T; Labella, D; Schuster, SJ; Park, J; Palomba, L; Zelenetz, A; Eyre, TA; Kater, AP; Seymour, JF; Mato, AR
Mato, AR (通讯作者)，Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.
BLOOD ADVANCES, 2022; 6 (15): 4553
